课题基金 / 基金详情

Community-viable screening for ASD in 9-month-old infants using quantitative eye-tracking assays of social visual engagement

Community-viable screening for ASD in 9-month-old infants using quantitative eye-tracking assays of social visual engagement
使用社交视觉参与的定量眼动追踪分析对 9 个月大的婴儿进行社区可行的 ASD 筛查
批准号:
10471352
负责人:
Warren Jones
金额:
$75.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-16 至 2025-08-31

项目摘要

项目成果

Warren Jones的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY This project is in response to NIMH RFA-MH-19-120 calling for the development and validation of new screening methods for autism spectrum disorder (ASD) that can be used in infancy (0-12 months of age). We will deploy a cost-effective, high-throughput methodology utilizing performance-based, objective, and highly quantitative eye- tracking assays of social visual engagement—the way in which infants visually explore, engage, and ultimately learn from and adapt to their surrounding world—collected on a standalone, mobile eye-tracking data collection device, created in our lab (the Marcus Autism Center Investigational Device, MAC-ID). We will collect eye- tracking data from a population-based sample of N=2,000 9-month-old infants recruited consecutively in primary care practices at the time of their 9-month well-child visits. These infants will be followed longitudinally from 9 until 26 months for completion of a series of sequential screening and clinical ascertainment procedures designed to maximize sensitivity and achieve clinician-best-estimate diagnostic assignments of ASD vs. non- ASD and Affected [including ASD and non-ASD developmental delays] vs. Unaffected. We will measure the accuracy of eye-tracking-based screening at the age of 9 months relative to clinician best estimate diagnosis at 24 months (primary analysis), and we will measure dimensional agreement between eye-tracking assays at 9 months relative to outcome levels of social disability, verbal ability, and nonverbal cognitive ability (secondary analyses). Our overarching goal is to develop high-quality, objective, performance-based tools that can function as an effective and community-viable means of screening for ASD and other actionable developmental delays in infancy, to ultimately facilitate improved access to and benefit from early intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Musical Rhythm Sensitivity to Scaffold Social Engagement in Autism Spectrum Disorder
Measuring gene-environment transactions to identify sensitive periods for infant social behavior & brain growth
  • 批准号:
    10355527
  • 项目类别:
  • 资助金额:
    $73.48万
  • 财政年份:
    2019
  • 负责人:
    Warren Jones
  • 依托单位:
Community-viable screening for ASD in 9-month-old infants using quantitative eye-tracking assays of social visual engagement
  • 批准号:
    10254287
  • 项目类别:
  • 资助金额:
    $75.98万
  • 财政年份:
    2019
  • 负责人:
    Warren Jones
  • 依托单位:
Measuring gene-environment transactions to identify sensitive periods for infant social behavior & brain growth
  • 批准号:
    9924648
  • 项目类别:
  • 资助金额:
    $76.18万
  • 财政年份:
    2019
  • 负责人:
    Warren Jones
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: